USE OF INTEGRIN ANTAGONIST AND A CHEMOTHERAPEUTIC AGENT IN THE TREATMENT OF NEOPLASIA

摘要

The present invention is directed to compounds of formula (I) and pharmaceutically acceptable salts and isomers thereof administered in combination with chemotherapeutic agents.